Birdwatch Note
2024-10-10 13:30:20 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
血液製剤によるHIV感染については国が加熱製剤の早期承認に尽力したと最高裁が認定しました。当時報道された陰謀論は全く事実として認定されず、承認後の旧製剤の回収命令を怠ったことのみが不作為の罪と認定されました https://www.courts.go.jp/app/files/hanrei_jp/923/035923_hanrei.pdf 被告の前任の郡司氏によれば、回収命令不指示以外は不可抗力です http://sleep.cocolog-nifty.com/blog/files/GUNJI.pdf HCV感染も病原体を特定できなかったことが主因です。国は加熱製剤に切り替える等の対策を講じましたが効果がありませんでした https://www.mhlw.go.jp/houdou/2002/08/h0829-3a.html 最高裁はイレッサ事件は薬害ではないと認定しました https://www.courts.go.jp/app/files/hanrei_jp/185/083185_hanrei.pdf https://iressa.sakura.ne.jp/iressa/static/summary.html 予防接種健康被害救済制度は救済目的の制度であり、この認定数は被害者数ではありません https://www.mhlw.go.jp/stf/shingi/shingi-shippei_127696_00001.html https://togetter.com/li/2416068
Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1844166796204744770
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1844369879018897857
- noteId - 1844369879018897857
- participantId -
- noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
- createdAtMillis - 1728567020550
- tweetId - 1844166796204744770
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 血液製剤によるHIV感染については国が加熱製剤の早期承認に尽力したと最高裁が認定しました。当時報道された陰謀論は全く事実として認定されず、承認後の旧製剤の回収命令を怠ったことのみが不作為の罪と認定されました https://www.courts.go.jp/app/files/hanrei_jp/923/035923_hanrei.pdf 被告の前任の郡司氏によれば、回収命令不指示以外は不可抗力です http://sleep.cocolog-nifty.com/blog/files/GUNJI.pdf HCV感染も病原体を特定できなかったことが主因です。国は加熱製剤に切り替える等の対策を講じましたが効果がありませんでした https://www.mhlw.go.jp/houdou/2002/08/h0829-3a.html 最高裁はイレッサ事件は薬害ではないと認定しました https://www.courts.go.jp/app/files/hanrei_jp/185/083185_hanrei.pdf https://iressa.sakura.ne.jp/iressa/static/summary.html 予防接種健康被害救済制度は救済目的の制度であり、この認定数は被害者数ではありません https://www.mhlw.go.jp/stf/shingi/shingi-shippei_127696_00001.html https://togetter.com/li/2416068
Note Ratings
rated at | rated by | |
2024-10-11 10:36:02 -0500 | Rating Details | |
2024-10-11 07:46:52 -0500 | Rating Details | |
2024-10-11 07:22:11 -0500 | Rating Details | |
2024-10-11 06:57:45 -0500 | Rating Details | |
2024-10-11 00:47:24 -0500 | Rating Details | |
2024-10-10 22:41:41 -0500 | Rating Details | |
2024-10-10 19:09:21 -0500 | Rating Details | |
2024-10-10 18:49:16 -0500 | Rating Details | |
2024-10-10 17:19:04 -0500 | Rating Details | |
2024-10-10 17:06:58 -0500 | Rating Details | |
2024-10-10 11:38:38 -0500 | Rating Details | |
2024-10-10 10:29:09 -0500 | Rating Details | |
2024-10-10 09:25:51 -0500 | Rating Details | |
2024-10-10 09:01:13 -0500 | Rating Details | |
2024-10-10 08:58:52 -0500 | Rating Details | |
2024-10-10 08:57:34 -0500 | Rating Details | |
2024-10-10 08:47:41 -0500 | Rating Details | |
2024-10-11 11:00:23 -0500 | Rating Details | |
2024-10-11 10:36:32 -0500 | Rating Details | |
2024-10-11 05:40:11 -0500 | Rating Details | |
2024-10-11 02:33:36 -0500 | Rating Details | |
2024-10-11 00:58:48 -0500 | Rating Details | |
2024-10-10 22:07:03 -0500 | Rating Details | |
2024-10-10 18:02:16 -0500 | Rating Details | |
2024-10-10 17:37:59 -0500 | Rating Details | |
2024-10-10 15:55:47 -0500 | Rating Details | |
2024-10-10 13:27:18 -0500 | Rating Details | |
2024-10-10 09:23:00 -0500 | Rating Details | |
2024-10-10 09:01:49 -0500 | Rating Details | |
2024-10-10 08:59:36 -0500 | Rating Details | |
2024-10-10 08:54:09 -0500 | Rating Details | |
2024-10-10 08:53:10 -0500 | Rating Details | |
2024-10-10 08:52:31 -0500 | Rating Details | |
2024-10-10 08:49:30 -0500 | Rating Details | |
2024-10-10 08:48:03 -0500 | Rating Details | |
2024-10-10 08:44:11 -0500 | Rating Details | |
2024-10-11 10:09:42 -0500 | Rating Details | |
2024-10-11 07:11:49 -0500 | Rating Details | |
2024-10-11 02:54:58 -0500 | Rating Details | |
2024-10-11 02:27:27 -0500 | Rating Details | |
2024-10-11 00:28:59 -0500 | Rating Details | |
2024-10-10 23:54:23 -0500 | Rating Details | |
2024-10-10 22:22:27 -0500 | Rating Details | |
2024-10-10 20:05:55 -0500 | Rating Details | |
2024-10-10 17:22:46 -0500 | Rating Details | |
2024-10-10 16:32:48 -0500 | Rating Details | |
2024-10-10 15:52:05 -0500 | Rating Details | |
2024-10-10 15:05:02 -0500 | Rating Details | |
2024-10-10 14:34:52 -0500 | Rating Details | |
2024-10-10 09:28:45 -0500 | Rating Details | |
2024-10-10 09:11:36 -0500 | Rating Details | |
2024-10-10 09:08:27 -0500 | Rating Details | |
2024-10-10 09:08:24 -0500 | Rating Details | |
2024-10-10 09:04:42 -0500 | Rating Details | |
2024-10-10 08:57:37 -0500 | Rating Details | |
2024-10-26 13:15:34 -0500 | Rating Details | |
2024-10-12 15:24:24 -0500 | Rating Details | |
2024-10-11 06:27:48 -0500 | Rating Details | |
2024-10-10 17:33:52 -0500 | Rating Details | |
2024-10-10 17:31:50 -0500 | Rating Details | |
2024-10-10 16:47:55 -0500 | Rating Details | |
2024-10-10 16:10:46 -0500 | Rating Details | |
2024-10-10 13:04:52 -0500 | Rating Details | |
2024-10-10 12:10:43 -0500 | Rating Details | |
2024-10-10 11:49:14 -0500 | Rating Details | |
2024-10-10 09:51:44 -0500 | Rating Details | |
2024-10-10 09:28:56 -0500 | Rating Details | |
2024-10-10 09:17:01 -0500 | Rating Details | |
2024-10-10 08:48:16 -0500 | Rating Details | |
2024-10-10 08:41:48 -0500 | Rating Details | |
2024-10-11 07:16:48 -0500 | Rating Details | |
2024-10-11 05:57:52 -0500 | Rating Details | |
2024-10-11 03:51:37 -0500 | Rating Details | |
2024-10-10 20:54:00 -0500 | Rating Details | |
2024-10-10 20:48:12 -0500 | Rating Details | |
2024-10-10 19:29:25 -0500 | Rating Details | |
2024-10-10 19:26:56 -0500 | Rating Details | |
2024-10-10 18:07:29 -0500 | Rating Details | |
2024-10-10 17:57:50 -0500 | Rating Details | |
2024-10-10 17:21:39 -0500 | Rating Details | |
2024-10-10 16:55:36 -0500 | Rating Details | |
2024-10-10 16:08:08 -0500 | Rating Details | |
2024-10-10 15:16:26 -0500 | Rating Details | |
2024-10-10 14:36:55 -0500 | Rating Details | |
2024-10-10 11:26:51 -0500 | Rating Details | |
2024-10-10 10:18:33 -0500 | Rating Details | |
2024-10-10 09:44:41 -0500 | Rating Details | |
2024-10-10 09:17:46 -0500 | Rating Details | |
2024-10-10 09:15:43 -0500 | Rating Details | |
2024-10-10 09:09:05 -0500 | Rating Details | |
2024-10-10 09:05:46 -0500 | Rating Details | |
2024-10-10 09:05:35 -0500 | Rating Details | |
2024-10-10 08:56:08 -0500 | Rating Details | |
2024-10-10 08:36:00 -0500 | Rating Details |